End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,020 KRW | +9.54% | -.--% | -67.58% |
May. 16 | NKMAX CO., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | NKMAX CO., Ltd. cancelled the transaction announced on October 20, 2023 | CI |
Performance
1 day | +9.54% | ||
3 months | +13.36% | ||
6 months | -67.15% | ||
Current year | -67.58% | ||
1 year | -70.16% | ||
3 years | -71.35% | ||
5 years | -70.83% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+9.54% | -.--% | -67.58% | -70.16% | 126M | ||
+1.70% | +9.50% | +18.72% | +44.44% | 125B | ||
+1.31% | +4.07% | +14.53% | +34.07% | 109B | ||
+3.10% | +9.94% | -2.88% | -5.73% | 24.74B | ||
+2.42% | +6.61% | +4.66% | -4.59% | 22.67B | ||
+0.34% | +0.47% | -9.98% | -29.27% | 18.14B | ||
-0.88% | +1.49% | -41.04% | -35.09% | 16.67B | ||
+2.53% | +5.12% | -11.83% | -28.31% | 16.64B | ||
+0.28% | -0.69% | +1.46% | +42.44% | 13.45B | ||
+0.03% | +3.05% | +24.22% | -5.06% | 11.32B | ||
+1.53% | +7.99% | +86.61% | +197.02% | 9.32B | ||
+3.57% | +8.13% | +16.94% | +44.23% | 7.99B | ||
+3.07% | +4.52% | +9.96% | +50.74% | 7.94B | ||
+5.64% | +3.71% | -27.47% | -33.19% | 7.95B | ||
+0.69% | +0.22% | -3.51% | +24.73% | 7.45B | ||
+1.08% | +7.17% | -8.46% | +12.73% | 6.4B | ||
Average | +2.24% | +3.94% | +0.27% | +14.94% | ||
Weighted average by Cap. | +1.60% | +5.62% | +9.63% | +26.00% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -67.58% | ||
2023 | -9.05% | ||
2022 | -38.98% | ||
2021 | +6.90% | ||
2020 | +94.44% | ||
2019 | -16.60% | ||
2018 | -35.25% | ||
2017 | +12.36% | ||
2016 | +11.42% | ||
2015 | +23.84% |
- Stock Market
- Equities
- A182400 Stock
- Quotes NKMAX CO., Ltd.